英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
467641查看　467641　在百度字典中的解释百度英翻中〔查看〕
467641查看　467641　在Google字典中的解释Google英翻中〔查看〕
467641查看　467641　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • 9 New Treatments for Psoriatic Arthritis in Development - GoodRx
    Psoriatic arthritis (PsA) treatments: Learn about the different medications used to treat psoriatic arthritis to help you find the best fit for your needs Initial results will likely be released in 2025 3 Tirzepatide As Mounjaro, tirzepatide is an effective Type 2 diabetes treatment
  • Phase III POETYK PsA Trials Show Significant Clinical Benefit with . . .
    These data, presented at the 2025 European Alliance of Associations for Rheumatology Congress, bolster the potential of Sotyktu as a first-in-class oral treatment option for PsA and follow similarly positive outcomes from the POETYK PsA-2 trial (NCT04908189), with efficacy maintained through one year of treatment 3,4 “Psoriatic arthritis can
  • Advances in Psoriasis Treatment for 2025: A New Era of Care
    These treatments: Require fewer injections (e g , quarterly dosing) Offer higher patient satisfaction due to convenience IL-17 Inhibitors Medications such as bimekizumab are gaining attention for their dual inhibition of IL-17A and IL-17F, leading to: Faster clearance of plaques Reduced joint symptoms in psoriatic arthritis 2 Small
  • Targeted Therapy for Psoriatic Arthritis - HealthCentral
    Targeted Therapy and the Future of Psoriatic Arthritis Treatment or obesity, plays into which treatment is best for you “For people with a BMI is 2025 and most recently updated March
  • Sitryx nominates SIT-047, a novel, oral MTHFD2 inhibitor, for clinical . . .
    Oxford, UK – 6 May 2025 SIT-047 offers first-in-class potential as a disease-modifying treatment for psoriatic arthritis By targeting MTHFD2, a key enzyme in one-carbon metabolism, SIT-047 is designed to regulate the activity of Th1 and Th17, immune cell subsets known to drive disease pathology in psoriatic arthritis
  • Oral Therapies Take Center Stage For PsO And PsA Treatment
    The drugs reported promising efficacy in moderate-to-severe psoriasis (PsO) and psoriatic arthritis (PsA), respectively, setting the stage for potential shifts in what are becoming increasingly crowded and competitive treatment landscapes Icotrokinra (JNJ-2113): Strong Phase 3 Performance And Head-to-Head Superiority Over Sotyktu
  • Biologics, Targeted Therapies Best for Acute PsA Dactylitis - Medscape
    TOPLINE: Biologic or targeted synthetic disease-modifying antirheumatic drugs (DMARDs) seemed to be the most effective treatments for patients with acute psoriatic arthritis (PsA) dactylitis
  • What Are the Treatment Guidelines for Psoriatic Arthritis?
    The goal of treatment for people living with psoriatic arthritis (PsA) is to delay or avoid joint damage At this time, there is no one standard of care for psoriatic arthritis (PsA) But treatments are changing at a rapid pace More drugs and therapies are available now than ever before 1 PsA is a complex disease to treat
  • Psoriatic Arthritis Treatment: Options, Medications, and Relief - WebMD
    The main treatments for psoriatic arthritis include nonsteroidal anti-inflammatory drugs (NSAIDs), disease-modifying antirheumatic drugs (DMARDs), which can be either a traditional or a biologic





中文字典-英文字典  2005-2009